- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Algorithme Pharma Inc
Total 2348 results
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedInvasive Fungal InfectionUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedArthritis, RheumatoidUnited States, Poland, Czechia, Bulgaria, Hungary, Mexico
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States, Germany, Italy
-
Astellas Pharma Global Development, Inc.TerminatedPainful Diabetic Peripheral Neuropathy (PDPN)United States
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP4058 | Food Effect of ASP4058United States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
InnoCare Pharma Inc.Not yet recruitingMantle Cell Lymphoma
-
ImmunoRx Pharma Inc.Recruiting
-
Telios Pharma, Inc.Recruiting
-
Astellas Pharma IncRecruiting
-
Telios Pharma, Inc.RecruitingAllergic ConjunctivitisUnited States
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
Acasti Pharma Inc.RecruitingAneurysmal Subarachnoid Hemorrhage (aSAH)United States
-
Cho Pharma Inc.RecruitingNon-Hodgkin LymphomaTaiwan, United States
-
aTyr Pharma, Inc.Recruiting
-
Kringle Pharma, Inc.Recruiting
-
Lantern Pharma Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenocarcinoma of LungUnited States
-
Astellas Pharma IncRecruiting
-
CanWell Pharma Inc.RecruitingSolid Tumor | Cancer MetastaticUnited States